II Robert C. Goeltz

CIK 1653881 · Chief Financial Officer · last filed 2026-05-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.07M

Companies

3

Total Filings

38

Lifetime Open-Market Net

-$1.47M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RCUS Chief Financial Officer 84,161 $23.80 $2.00M -$1.04M 21 2026-05-12
Unity Biotechnology, Inc. (UBX) Delisted Chief Financial Officer 161,027 $0.20 $32.2K $0 8 2020-06-24
CTMX Chief Financial Officer 22,769 $3.01 $68.5K -$426.3K 9 2017-05-16

Recent Filings · Page 2 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-01-25 RCUS Grant (A) +21,300 $0 EDGAR
2024-01-04 RCUS Sell (S) −2,004 -$40.1K EDGAR
2023-12-20 RCUS Disp (D) −5,557 -$99.6K EDGAR
2023-06-09 RCUS Sell (S) −4,049 -$81.1K EDGAR
2023-01-25 RCUS Grant (A) +34,000 $0 EDGAR
2022-12-16 RCUS Sell (S) −2,453 -$75.4K EDGAR
2022-03-10 RCUS Grant (A) +15,500 $0 EDGAR
2021-12-20 RCUS Sell (S) −1,106 -$44.4K EDGAR
2021-01-20 RCUS Grant (A) +12,500 $0 EDGAR
2020-09-09 RCUS Buy (P) +5,000 $107.8K EDGAR
Showing 1120 of 38
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.